Author

Nitin Jain

The University of Texas MD Anderson Cancer CenterPrimary ORCID profile (0000-0003-0114-8384 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Nitin JainiD1 paper · The University of Texas MD Anderson Cancer Center

Biology Disciplines

Click to filter author papers

Genetics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 1 Organism:human· 1 Approach:statistical model· 1 Assay:whole-exome sequencing· 1

Frequent Co-Authors

Christopher R. FlowersiD· 1 shared David Andrew SallmaniD· 1 shared David M. SwobodaiD· 1 shared Elizabeth J. ShpalliD· 1 shared Eric PadroniD· 1 shared Feng WangiD· 1 shared Frederick Lundry LockeiD· 1 shared Guilin TangiD· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenetics

Christopher R. FlowersORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Clonal hematopoiesis is associated with increased toxicity in large B-cell lymphoma patients treated with chimeric antigen receptor T cell therapy

Neeraj Y. Saini, David M. Swoboda, Uri Greenbaum, Jungsheng Ma, Romil D. Patel, Kartik Devashish, Kaberi Das, Mark R. Tanner, Paolo Strati, Ranjit K. Nair, Luis Fayad, Sairah Ahmed, Hun Ju Lee, Swaminathan P. Iyer, Raphael Eric Steiner, , Koichi Takahashi

This study finds that clonal hematopoiesis mutations, particularly in DNMT3A, TET2, and ASXL1, are linked to increased toxicity in patients undergoing anti-CD19 CAR T-cell therapy for large B-cell lymphoma.

bioRxiv · Sep 28, 2021 · PreprintGenetics